vs
Evercore Inc.（EVR）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是Evercore Inc.的1.0倍（$1.4B vs $1.4B），瑞思迈净利率更高（27.6% vs 23.0%，领先4.6%），Evercore Inc.同比增速更快（100.3% vs 11.0%），过去两年Evercore Inc.的营收复合增速更高（42.2% vs 7.8%）
Evercore Inc.（前称Evercore Partners）是1995年由罗杰·奥尔特曼、大卫·奥芬森德、奥斯汀·博伊特纳联合创立的全球独立投资银行咨询机构。成立至今，公司已为总规模超4.7万亿美元的并购、重组交易提供专业咨询服务，在全球投行业务领域拥有较高声誉。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
EVR vs RMD — 直观对比
营收规模更大
RMD
是对方的1.0倍
$1.4B
营收增速更快
EVR
高出89.3%
11.0%
净利率更高
RMD
高出4.6%
23.0%
两年增速更快
EVR
近两年复合增速
7.8%
损益表 — Q1 FY2026 vs Q4 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.4B | $1.4B |
| 净利润 | $322.7M | $392.6M |
| 毛利率 | — | 61.8% |
| 营业利润率 | — | 34.6% |
| 净利率 | 23.0% | 27.6% |
| 营收同比 | 100.3% | 11.0% |
| 净利润同比 | 106.1% | 13.9% |
| 每股收益（稀释后） | $7.20 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EVRRMD
| Q2 26 | — | $1.4B | ||
| Q1 26 | $1.4B | $1.4B | ||
| Q4 25 | $1.3B | $1.4B | ||
| Q3 25 | $1.0B | $1.3B | ||
| Q2 25 | $838.0M | $1.3B | ||
| Q1 25 | $699.0M | $1.3B | ||
| Q4 24 | $979.5M | $1.3B | ||
| Q3 24 | $738.4M | $1.2B |
净利润EVRRMD
| Q2 26 | — | $392.6M | ||
| Q1 26 | $322.7M | $398.7M | ||
| Q4 25 | $204.0M | $392.6M | ||
| Q3 25 | $144.6M | $348.5M | ||
| Q2 25 | $97.2M | $379.7M | ||
| Q1 25 | $146.2M | $365.0M | ||
| Q4 24 | $140.4M | $344.6M | ||
| Q3 24 | $78.4M | $311.4M |
毛利率EVRRMD
| Q2 26 | — | 61.8% | ||
| Q1 26 | — | 62.2% | ||
| Q4 25 | — | 61.8% | ||
| Q3 25 | — | 61.5% | ||
| Q2 25 | — | 60.8% | ||
| Q1 25 | — | 59.3% | ||
| Q4 24 | — | 58.6% | ||
| Q3 24 | — | 58.6% |
营业利润率EVRRMD
| Q2 26 | — | 34.6% | ||
| Q1 26 | — | 34.9% | ||
| Q4 25 | 24.2% | 34.6% | ||
| Q3 25 | 20.8% | 33.4% | ||
| Q2 25 | 18.0% | 33.7% | ||
| Q1 25 | 16.0% | 33.0% | ||
| Q4 24 | 21.8% | 32.5% | ||
| Q3 24 | 16.7% | 31.6% |
净利率EVRRMD
| Q2 26 | — | 27.6% | ||
| Q1 26 | 23.0% | 27.9% | ||
| Q4 25 | 15.7% | 27.6% | ||
| Q3 25 | 13.8% | 26.1% | ||
| Q2 25 | 11.6% | 28.2% | ||
| Q1 25 | 20.9% | 28.3% | ||
| Q4 24 | 14.3% | 26.9% | ||
| Q3 24 | 10.6% | 25.4% |
每股收益（稀释后）EVRRMD
| Q2 26 | — | $2.68 | ||
| Q1 26 | $7.20 | $2.74 | ||
| Q4 25 | $4.80 | $2.68 | ||
| Q3 25 | $3.41 | $2.37 | ||
| Q2 25 | $2.36 | $2.58 | ||
| Q1 25 | $3.48 | $2.48 | ||
| Q4 24 | $3.32 | $2.34 | ||
| Q3 24 | $1.86 | $2.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $1.4B |
| 总债务越低越好 | — | $663.8M |
| 股东权益账面价值 | — | $6.3B |
| 总资产 | — | $8.5B |
| 负债/权益比越低杠杆越低 | — | 0.11× |
8季度趋势，按日历期对齐
现金及短期投资EVRRMD
| Q2 26 | — | $1.4B | ||
| Q1 26 | — | $1.7B | ||
| Q4 25 | $3.0B | $1.4B | ||
| Q3 25 | $2.4B | $1.4B | ||
| Q2 25 | $1.7B | $1.2B | ||
| Q1 25 | $1.4B | $932.7M | ||
| Q4 24 | $2.4B | $521.9M | ||
| Q3 24 | $1.8B | $426.4M |
总债务EVRRMD
| Q2 26 | — | $663.8M | ||
| Q1 26 | — | $664.1M | ||
| Q4 25 | — | $403.9M | ||
| Q3 25 | — | $408.7M | ||
| Q2 25 | — | $658.4M | ||
| Q1 25 | — | $663.1M | ||
| Q4 24 | — | $662.9M | ||
| Q3 24 | — | $667.6M |
股东权益EVRRMD
| Q2 26 | — | $6.3B | ||
| Q1 26 | — | $6.5B | ||
| Q4 25 | $2.0B | $6.3B | ||
| Q3 25 | $1.8B | $6.1B | ||
| Q2 25 | $1.7B | $6.0B | ||
| Q1 25 | $1.5B | $5.5B | ||
| Q4 24 | $1.7B | $5.3B | ||
| Q3 24 | $1.6B | $5.2B |
总资产EVRRMD
| Q2 26 | — | $8.5B | ||
| Q1 26 | — | $8.8B | ||
| Q4 25 | $5.4B | $8.5B | ||
| Q3 25 | $4.4B | $8.3B | ||
| Q2 25 | $3.7B | $8.2B | ||
| Q1 25 | $3.3B | $7.6B | ||
| Q4 24 | $4.2B | $7.1B | ||
| Q3 24 | $3.6B | $7.2B |
负债/权益比EVRRMD
| Q2 26 | — | 0.11× | ||
| Q1 26 | — | 0.10× | ||
| Q4 25 | — | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.13× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EVR
| Advisory Fees (1) | $1.2B | 89% |
| Commissions and Related Revenue | $62.7M | 4% |
| Underwriting Fees | $55.1M | 4% |
| Asset Management and Administration Fees (2) | $23.7M | 2% |
| Other Revenue, net | $15.4M | 1% |
RMD
暂无分部数据
